Sign in
Not yet recruitingNo phase

Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2

Key facts

Who runs it
Hamilton Health Sciences Corporation
Where
Canada3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
20,000 people, planned
Started
Jun 2026
Expected to end
Jun 2032
Type of study
Observational
Treatments tested
  • Continuous vital signs measurement device
Record updated
14 April 2026

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • age ≥65 years
  • underwent non-cardiac surgery with general, neuraxial, local, or regional anesthesia; and
  • expected length of hospital stay of 3 or more days

Who cannot take part

  • hearing aid(s) or cochlear implant(s) in left ear
  • previous enrollment in the VISION-2 Study
  • intolerance/allergy to adhesive
  • history of dementia, or
  • pacemaker/implantable cardioverter-defibrillator (ICD)
  • externally programmable cerebrospinal fluid shunt
  • deep brain stimulator

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

VISION-2 is an international, multi-site, prospective observational cohort study of 20,000 patients undergoing noncardiac surgery. Continuous biometric data will be blindly collected for the first 30 postoperative days, in hospital and at home, using Vitaliti™. Following study enrollment and baseline data collection, follow up visits will occur in-hospital, at 30-days, and 1-year post-operatively.

Read full original descriptionShow less

VISION-2 has 3 primary objectives, among participants who underwent noncardiac surgery, the investigators will: 1) determine the pattern and frequency of physiological precursors (i.e., biophysical signals) to MINS, BIMS, sepsis, and infection without sepsis; 2) build prediction models from these biophysical signals and their extracted features through supervised machine learning, for the prediction and early detection of those complications; and 3) build a biobank for evaluation of novel biomarkers.

Treatments tested

  • Continuous vital signs measurement device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
14 April 2026